Barclays PLC Raises Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Barclays PLC increased its holdings in Definitive Healthcare Corp. (NASDAQ:DH) by 318.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 81,916 shares of the company’s stock after purchasing an additional 62,354 shares during the quarter. Barclays PLC’s holdings in Definitive Healthcare were worth $366,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of DH. Point72 DIFC Ltd raised its holdings in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares during the period. Intech Investment Management LLC acquired a new position in shares of Definitive Healthcare in the 3rd quarter valued at $55,000. Bleakley Financial Group LLC purchased a new stake in Definitive Healthcare during the 3rd quarter valued at approximately $74,000. Glenmede Trust Co. NA raised its position in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after buying an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Definitive Healthcare in the 3rd quarter valued at approximately $84,000. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares of the company’s stock, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 14.84% of the company’s stock.

Definitive Healthcare Stock Down 0.3 %

DH stock opened at $3.94 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The firm has a market capitalization of $455.15 million, a P/E ratio of -1.27, a P/E/G ratio of 3.26 and a beta of 1.41. Definitive Healthcare Corp. has a 52-week low of $3.19 and a 52-week high of $10.62. The company’s 50 day simple moving average is $4.35 and its 200-day simple moving average is $4.48.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on DH shares. Stephens began coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target for the company. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday. Finally, Barclays reiterated an “underweight” rating and issued a $4.00 price objective on shares of Definitive Healthcare in a report on Monday, January 13th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Definitive Healthcare currently has an average rating of “Hold” and a consensus price target of $5.72.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.